Tobacco Smoking, Lung Cancer, and Therapy in Iraq: Current Perspective.

Buthainah A Ibrahim, Saif Al-Humaish, Mohammed A I Al-Obaide
Author Information
  1. Buthainah A Ibrahim: Department of Physics, Diyala University, Baquba, Iraq.
  2. Saif Al-Humaish: Biomedica, LLC, Sterling Heights, MI, United States.
  3. Mohammed A I Al-Obaide: Texas Tech University Health Sciences Center, Amarillo, TX, United States.

Abstract

Tobacco smoking is a research topic of high interest to the public health in Iraq. Although Iraq is a country with a high percentage of smokers, we noticed the dearth of adequate studies and programs to deal with this problem. The percentage of smokers exceed 30% of the population and smoking problem becomes a permanent habit in adults and young people. The problems associated with tobacco smoking behavior related to individuals' post-traumatic stress disorder following post-war conflicts, and the social and cultural environment. The health consequences of tobacco smoking can harm almost every organ in the body, and there are reports confirmed the tobacco smoking is a high-risk factor for lung cancer and other diseases. The relative risk of lung cancer increases with increasing duration and intensity of smoking. Also, smoking associated with bladder, prostate, and head and neck cancers, in addition to respiratory diseases. Intervention efforts should focus on reducing the prevalence of cigarette smoking, introduce effective treatments for cancer and quit smoking. In this perspective article, we present our viewpoint and three scenarios to deal with the problem of tobacco smoking in Iraq. We recommend introducing educational, health and legislative policies for quitting smoking and using effective treatments for cancer.

Keywords

References

  1. Oncology (Williston Park). 2008 Jun;22(7):748-54; discussion 754, 757 [PMID: 18619120]
  2. Front Genet. 2018 Jun 13;9:198 [PMID: 29951083]
  3. Prev Med. 1999 Sep;29(3):210-5 [PMID: 10479609]
  4. Community Dent Oral Epidemiol. 1995 Aug;23(4):254-5 [PMID: 7587150]
  5. Cochrane Database Syst Rev. 2002;(3):CD001007 [PMID: 12137615]
  6. J Adolesc Health. 2005 Sep;37(3):202-10 [PMID: 16109339]
  7. Transl Lung Cancer Res. 2015 Aug;4(4):327-38 [PMID: 26380174]
  8. Ont Health Technol Assess Ser. 2010;10(1):1-44 [PMID: 23074386]
  9. MMWR Surveill Summ. 2016 Jun 10;65(6):1-174 [PMID: 27280474]
  10. Asian Pac J Cancer Prev. 2014;15(1):385-90 [PMID: 24528061]
  11. Front Public Health. 2018 Mar 20;6:84 [PMID: 29616208]
  12. Cochrane Database Syst Rev. 2000;(3):CD001294 [PMID: 10908490]
  13. Saudi Med J. 2016 Nov;37(11):1214-1219 [PMID: 27761559]
  14. Mol Oncol. 2018 May;12(5):705-723 [PMID: 29570930]
  15. Cochrane Database Syst Rev. 2003;(3):CD001746 [PMID: 12917911]
  16. Rev Urol. 2014;16(2):67-75 [PMID: 25009446]
  17. J Pharm Bioallied Sci. 2016 Apr-Jun;8(2):146-51 [PMID: 27134468]
  18. J Res Health Sci. 2015 Winter;15(1):42-6 [PMID: 25821025]
  19. Int J Prev Med. 2016 Jan 11;7:7 [PMID: 26941908]
  20. Appl Nurs Res. 2009 May;22(2):126-32 [PMID: 19427575]
  21. Clin Chest Med. 2014 Mar;35(1):17-27 [PMID: 24507834]
  22. Health Soc Work. 1997 Feb;22(1):47-52 [PMID: 9132363]
  23. Nicotine Tob Res. 2007 Nov;9(11):1071-84 [PMID: 17978982]
  24. Carcinogenesis. 2008 Aug;29(8):1467-74 [PMID: 18550573]
  25. Eur Urol. 2014 Dec;66(6):1054-64 [PMID: 25242554]
  26. JAMA. 2011 Aug 17;306(7):737-45 [PMID: 21846855]
  27. Health Policy Plan. 2014 Sep;29(6):784-94 [PMID: 23958628]
  28. MMWR Morb Mortal Wkly Rep. 2017 Jan 06;65(52):1457-1464 [PMID: 28056007]
  29. MMWR Morb Mortal Wkly Rep. 2016 Nov 11;65(44):1212-1218 [PMID: 27832048]
  30. Nicotine Tob Res. 2009 Oct;11(10):1189-95 [PMID: 19648174]
  31. Annu Rev Public Health. 1982;3:179-99 [PMID: 6756429]
  32. Cancer J. 2009 Jul-Aug;15(4):312-8 [PMID: 19672148]
  33. Tob Control. 2010 Oct;19 Suppl 2:i18-23 [PMID: 20935195]
  34. Environ Health. 2005 May 12;4(1):7 [PMID: 15890079]
  35. Clin Adv Hematol Oncol. 2014 Dec;12(12):861, 865-6, 869 [PMID: 25674847]
  36. Prev Med. 2008 Apr;46(4):289-97 [PMID: 18093639]
  37. Front Public Health. 2018 Apr 11;6:96 [PMID: 29707532]
  38. Eval Health Prof. 2008 Sep;31(3):297-305 [PMID: 18566160]
  39. Cancer J. 2014 Nov-Dec;20(6):415-20 [PMID: 25415688]
  40. Proc Am Thorac Soc. 2008 Dec 1;5(8):811-5 [PMID: 19017734]
  41. Med Dosim. 2017 Spring;42(1):7-11 [PMID: 27839693]
  42. J Health Soc Behav. 1973 Jun;14(2):144-52 [PMID: 4717127]
  43. Cancer. 2007 Oct 1;110(7):1593-601 [PMID: 17724671]
  44. Tob Use Insights. 2014 Feb 10;7:9-14 [PMID: 25741180]
  45. Ecancermedicalscience. 2017 Apr 28;11:735 [PMID: 28596801]
  46. Am J Public Health. 2010 Apr;100(4):693-701 [PMID: 19608952]
  47. Jpn J Clin Oncol. 2016 Jun;46(6):580-95 [PMID: 27369767]
  48. Tob Control. 2003 Dec;12 Suppl 4:IV46-53 [PMID: 14645940]

Word Cloud

Created with Highcharts 10.0.0smokingtobaccocancerhealthIraqproblemTobaccohighpercentagesmokersdealassociatedlungdiseaseseffectivetreatmentstherapyresearchtopicinterestpublicAlthoughcountrynoticeddearthadequatestudiesprogramsexceed30%populationbecomespermanenthabitadultsyoungpeopleproblemsbehaviorrelatedindividuals'post-traumaticstressdisorderfollowingpost-warconflictssocialculturalenvironmentconsequencescanharmalmosteveryorganbodyreportsconfirmedhigh-riskfactorrelativeriskincreasesincreasingdurationintensityAlsobladderprostateheadneckcancersadditionrespiratoryInterventioneffortsfocusreducingprevalencecigaretteintroducequitperspectivearticlepresentviewpointthreescenariosrecommendintroducingeducationallegislativepoliciesquittingusingSmokingLungCancerTherapyIraq:CurrentPerspectiverisksincidencephotonproton

Similar Articles

Cited By